There are 2949 resources available
LBA36 - Safety and antitumor activity of dostarlimab in patients (pts) with advanced or recurrent DNA mismatch repair deficient (dMMR) or proficient (MMRp) endometrial cancer (EC): Results from GARNET
Presenter: Ana Oaknin
Session: Mini Oral - Gynaecological cancers 2
Resources:
Abstract
Slides
Webcast
1674MO - ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: Implications for SARS-CoV-2
Presenter: Riyue Bao
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA81 - Keeping exhausted T-cells in check in COVID-19
Presenter: Pierre Van Mol
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA82 - Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study
Presenter: Melissa Bersanelli
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA22 - Imaging based PCa screening among BRCA mutation carriers: Results from the first round of screening
Presenter: David Margel
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
615MO - Phase Ib/II study of VERU-111, novel, oral tubulin inhibitor, in men with metastatic castration resistant prostate cancer (mCRPC) who failed an androgen blocking agent
Presenter: Mark Markowski
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
616MO - Efficacy of BN-brachyury (BNVax) + bintrafusp alfa (BA) + N-803 in castration-resistant prostate cancer (CRPC): Results from a preliminary analysis of the Quick Efficacy Seeking Trial (QuEST1)
Presenter: Jason Redman
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
617MO - Repurposing metformin as an anticancer drug: Preliminary results of randomized controlled trial in advanced prostate cancer (MANSMED)
Presenter: Reham Alghandour
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
618MO - Local therapy to the primary tumour for newly diagnosed, oligo-metastatic prostate cancer: A prospective randomized, phase II, open-label trial
Presenter: Bo Dai
Session: Mini Oral - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
1585MO - Factors associated with change in overall survival and quality of life between time of approval and post-marketing among anti-cancer therapies
Presenter: Aida Bujosa Rodríguez
Session: Mini Oral - Public policy
Resources:
Abstract
Slides
Webcast